[HTML][HTML] lncRNA UCA1 mediates resistance to cisplatin by regulating the miR-143/FOSL2-signaling pathway in ovarian cancer
Z Li, H Niu, Q Qin, S Yang, Q Wang, C Yu, Z Wei… - … Therapy-Nucleic Acids, 2019 - cell.com
The aim of this study was to explore the roles of the long noncoding RNA (lncRNA) urothelial
carcinoma-associated 1 (UCA1) on cisplatin resistance in ovarian cancer and the underlying …
carcinoma-associated 1 (UCA1) on cisplatin resistance in ovarian cancer and the underlying …
[引用][C] lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer
Z Li, H Niu, Q Qin, S Yang, Q Wang, C Yu… - … Therapy-Nucleic Acids, 2019 - cir.nii.ac.jp
lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling
Pathway in Ovarian Cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Pathway in Ovarian Cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
[HTML][HTML] lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer
Z Li, H Niu, Q Qin, S Yang, Q Wang, C Yu… - Molecular Therapy …, 2019 - ncbi.nlm.nih.gov
The aim of this study was to explore the roles of the long noncoding RNA (lncRNA) urothelial
carcinoma-associated 1 (UCA1) on cisplatin resistance in ovarian cancer and the underlying …
carcinoma-associated 1 (UCA1) on cisplatin resistance in ovarian cancer and the underlying …
lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer
Z Li, H Niu, Q Qin, S Yang, Q Wang… - Molecular therapy …, 2019 - pubmed.ncbi.nlm.nih.gov
The aim of this study was to explore the roles of the long noncoding RNA (lncRNA) urothelial
carcinoma-associated 1 (UCA1) on cisplatin resistance in ovarian cancer and the underlying …
carcinoma-associated 1 (UCA1) on cisplatin resistance in ovarian cancer and the underlying …
[HTML][HTML] lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer
Z Li, H Niu, Q Qin, S Yang, Q Wang, C Yu, Z Wei… - … Therapy-Nucleic Acids, 2019 - Elsevier
The aim of this study was to explore the roles of the long noncoding RNA (lncRNA) urothelial
carcinoma-associated 1 (UCA1) on cisplatin resistance in ovarian cancer and the underlying …
carcinoma-associated 1 (UCA1) on cisplatin resistance in ovarian cancer and the underlying …
lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer
Z Li, H Niu, Q Qin, S Yang, Q Wang… - Molecular Therapy …, 2019 - search.proquest.com
The aim of this study was to explore the roles of the long noncoding RNA (lncRNA) urothelial
carcinoma-associated 1 (UCA1) on cisplatin resistance in ovarian cancer and the underlying …
carcinoma-associated 1 (UCA1) on cisplatin resistance in ovarian cancer and the underlying …
lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer.
Z Li, H Niu, Q Qin, S Yang, Q Wang, C Yu… - Molecular therapy …, 2019 - europepmc.org
The aim of this study was to explore the roles of the long noncoding RNA (lncRNA) urothelial
carcinoma-associated 1 (UCA1) on cisplatin resistance in ovarian cancer and the underlying …
carcinoma-associated 1 (UCA1) on cisplatin resistance in ovarian cancer and the underlying …